Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties

scientific article

Spray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJPHARM.2008.09.029
P698PubMed publication ID18929634

P50authorLidia TajberQ40692418
Anne Marie HealyQ40692453
P2093author name stringO I Corrigan
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectstatisticsQ12483
P304page(s)86-96
P577publication date2008-09-25
P1433published inInternational Journal of PharmaceuticsQ6051539
P1476titleSpray drying of budesonide, formoterol fumarate and their composites-II. Statistical factorial design and in vitro deposition properties
P478volume367

Reverse relations

cites work (P2860)
Q92230068A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery
Q33691795Analysis of Process Parameters Affecting Spray-Dried Oily Core Nanocapsules Using Factorial Design
Q49496136Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability
Q51706707Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.
Q57822083Effect of electrospinning process variables on the size of polymer fibers and bead-on-string structures established with a 2 factorial design
Q41124468Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin
Q41275250Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics
Q26748640Revealing facts behind spray dried solid dispersion technology used for solubility enhancement
Q92534473The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers